Amyris Inc  

(Public, NASDAQ:AMRS)   Watch this stock  
Find more results for AMRS
0.589
+0.029 (5.18%)
May 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.56 - 0.61
52 week 0.49 - 2.62
Open 0.60
Vol / Avg. 1.15M/734,432.00
Mkt cap 137.33M
P/E     -
Div/yield     -
EPS -1.41
Shares 211.17M
Beta 1.04
Inst. own 46%
Aug 4, 2016
Q2 2016 Amyris Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
Jun 7, 2016
Amyris Inc at Stifel Technology Internet & Media Conference - 12:45PM EDT - Add to calendar
May 24, 2016
Amyris Inc at Naseba Investors Conference
May 19, 2016
Amyris Inc Annual Shareholders Meeting (Estimated)
May 17, 2016
Amyris Inc Annual Shareholders Meeting
May 17, 2016
Amyris Inc at Oppenheimer Emerging Growth Conference
May 10, 2016
Q1 2016 Amyris Inc Earnings Call - Webcast
May 10, 2016
Q1 2016 Amyris Inc Earnings Release
Mar 9, 2016
Q4 2015 Amyris Inc Earnings Call - Webcast
Mar 9, 2016
Q4 2015 Amyris Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -173.74% -626.21%
Operating margin -303.65% -438.25%
EBITD margin - -280.86%
Return on average assets -58.98% -132.71%
Return on average equity - -
Employees 418 -
CDP Score - -

Address

5885 Hollis St Ste 100
EMERYVILLE, CA 94608-2405
United States - Map
+1-510-4500761 (Phone)
+1-510-2252645 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Amyris, Inc. is a renewable products company. The Company is focused on providing sustainable alternatives to a range of petroleum-sourced products used in consumer care, specialty chemical and transportation fuel markets around the world. The Company developed microbial engineering and screening technologies that modify the way microorganisms' process sugars. The Company using its industrial bioscience technology to design microbes, primarily yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into renewable hydrocarbons. The Company has focused its commercialization efforts on a renewable hydrocarbon molecule called farnesene (Biofene), which forms the basis for a range of products including emollients, flavors and fragrance oils and diesel fuel.

Officers and directors

John G. Melo President, Chief Executive Officer, Director
Age: 49
Bio & Compensation  - Reuters
Raffi Asadorian Chief Financial Officer
Age: 45
Bio & Compensation  - Reuters
Joel Cherry Ph.D. President - Research and Development
Age: 54
Bio & Compensation  - Reuters
Karen D. Rohde Chief Human Resources Officer
Bio & Compensation  - Reuters
Nicholas Khadder General Counsel, Corporate Secretary
Age: 41
Bio & Compensation  - Reuters
Philippe Boisseau Director
Age: 53
Bio & Compensation  - Reuters
Margaret H. Georgiadis Director
Age: 52
Bio & Compensation  - Reuters
Abraham Klaeijsen Director
Bio & Compensation  - Reuters
Patrick Y. Yang Ph.D. Director
Age: 68
Bio & Compensation  - Reuters
Abdullah Bin Khalifa Al Thani Independent Director
Age: 55
Bio & Compensation  - Reuters